Phastar CEO, Graham Clark, recently spoke with Contract Pharma regarding the current trends, challenges, and growth drivers in the CRO industry. In this wide-ranging discussion, Graham emphasised the need for CROs to be adaptable, innovative, and proactive to meet the evolving needs of the pharmaceutical and biotech industries while navigating complex regulatory environments and technological advancements.
To read the full article visit contractpharma.com.